ArticleScientific reports2021

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Ki Won Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.